CoChat

Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein

Open access
Fischer, Martin, Quaas, Marianne, Wintsche, Axel, Müller, Gerd A., Engeland, Kurt · 2014 · Nucleic Acids Research
Cited by 59

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Infection by oncogenic viruses is a frequent cause for tumor formation as observed in cervical cancer. Viral oncoproteins cause inactivation of p53 function and false transcriptional regulation of central cell cycle genes. Here we analyze the regulation of Plk4, serving as an example of many cell cycle- and p53-regulated genes. Cell cycle genes are often repressed via CDE and CHR elements in their promoters and activated by NF-Y binding to CCAAT-boxes. In contrast, general activation of Plk4 depends on NRF1 and CRE sites. Bioinformatic analyses imply that NRF1 and CRE are central elements of the transcriptional network controlling cell cycle genes. We identify CDE and CHR sites in the Plk4 promoter, which are necessary for binding of the DREAM (DP, RB-like, E2F4 and MuvB) complex and for mediating repression in G0/G1. When cells progress to G2 and mitosis, DREAM is replaced by the MMB (Myb-MuvB) complex that only requires the CHR element for binding. Plk4 expression is downregulated by the p53-p21(WAF1/CIP1)-DREAM signaling pathway through the CDE and CHR sites. Cell cycle- and p53-dependent repression is abrogated by HPV E7 oncoprotein. Together with genome-wide analyses our results imply that many cell cycle genes upregulated in tumors by viral infection are bound by DREAM through CDE/CHR sites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkt849

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 74

  1. Fode, 1994, Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation, Proc. Natl Acad. Sci. USA, 91, 6388, 10.1073/pnas.91.14.6388 · DOI
  2. Habedanck, 2005, The Polo kinase Plk4 functions in centriole duplication, Nat. Cell Biol., 7, 1140, 10.1038/ncb1320 · DOI · Paper page
  3. Sillibourne, 2010, Polo–like kinase 4: the odd one out of the family, Cell Div., 5, 25, 10.1186/1747-1028-5-25 · DOI
  4. de Carcer, 2011, From Plk1 to Plk5: functional evolution of polo-like kinases, Cell Cycle, 10, 2255, 10.4161/cc.10.14.16494 · DOI · Paper page
  5. Cunha-Ferreira, 2009, The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4, Curr. Biol., 19, 43, 10.1016/j.cub.2008.11.037 · DOI · Paper page
  6. Rogers, 2009, The SCF Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication, J. Cell Biol., 184, 225, 10.1083/jcb.200808049 · DOI · Paper page
  7. Fode, 1996, Constitutive expression of murine Sak-a suppresses cell growth and induces multinucleation, Mol. Cell Biol., 16, 4665, 10.1128/MCB.16.9.4665 · DOI
  8. Müller, 2010, The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription, FEBS J., 277, 877, 10.1111/j.1742-4658.2009.07508.x · DOI · Paper page
  9. Müller, 2007, Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences, Mol. Biol. Evol., 24, 814, 10.1093/molbev/msl210 · DOI
  10. Dolfini, 2012, NF-Y and the transcriptional activation of CCAAT promoters, Crit Rev. Biochem. Mol. Biol., 47, 29, 10.3109/10409238.2011.628970 · DOI · Paper page
  11. Salsi, 2003, Interactions between p300 and multiple NF-Y trimers govern Cyclin B2 promoter function, J. Biol. Chem., 278, 6642, 10.1074/jbc.M210065200 · DOI · Paper page
  12. Müller, 2012, The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes, Nucleic Acids Res., 40, 1561, 10.1093/nar/gkr793 · DOI · Paper page
  13. Korenjak, 2004, Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes, Cell, 119, 181, 10.1016/j.cell.2004.09.034 · DOI · Paper page
  14. Harrison, 2006, Some C. elegans class B synthetic multivulva proteins encode a conserved LIN-35 Rb-containing complex distinct from a NuRD-like complex, Proc. Natl Acad. Sci. USA, 103, 16782, 10.1073/pnas.0608461103 · DOI · Paper page
  15. Pilkinton, 2007, Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1, J. Biol. Chem., 282, 168, 10.1074/jbc.M609924200 · DOI · Paper page
  16. Knight, 2009, A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells, Oncogene, 28, 1737, 10.1038/onc.2009.22 · DOI
  17. Osterloh, 2007, The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis, EMBO J., 26, 144, 10.1038/sj.emboj.7601478 · DOI
  18. Böhlig, 2011, One function—multiple mechanisms: the manifold activities of p53 as a transcriptional repressor, J. Biomed. Biotechnol., 2011, 464916, 10.1155/2011/464916 · DOI · Paper page
  19. Fukasawa, 2008, P53, cyclin-dependent kinase and abnormal amplification of centrosomes, Biochim. Biophys. Acta, 1786, 15
  20. Moody, 2010, Human papillomavirus oncoproteins: pathways to transformation, Nat. Rev. Cancer, 10, 550, 10.1038/nrc2886 · DOI · Paper page
  21. Nor Rashid, 2011, Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells, J. Gen. Virol., 92, 2620, 10.1099/vir.0.035352-0 · DOI · Paper page
  22. Duensing, 2001, Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype, Cancer Res., 61, 2356
  23. Korzeniewski, 2009, Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels, Cancer Res., 69, 6668, 10.1158/0008-5472.CAN-09-1284 · DOI
  24. Holland, 2012, The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle, Genes Dev., 26, 2684, 10.1101/gad.207027.112 · DOI
  25. Korzeniewski, 2011, The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression, Mol. Cancer, 10, 61, 10.1186/1476-4598-10-61 · DOI · Paper page
  26. Tarasov, 2008, B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells, PLoS One, 3, e2478, 10.1371/journal.pone.0002478 · DOI
  27. el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
  28. Gonzalez, 2001, Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7, J. Virol., 75, 7583, 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
  29. Miyamoto, 2011, Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway, Invest Ophthalmol. Vis. Sci., 52, 1055, 10.1167/iovs.10-5777 · DOI
  30. Kirschner, 2008, Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site, Nucleic Acids Res., 36, 2969, 10.1093/nar/gkn132 · DOI · Paper page
  31. Tavner, 2007, Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells, Oncogene, 26, 2727, 10.1038/sj.onc.1210087 · DOI
  32. Izumi, 2003, p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene, Biochem. J., 373, 713, 10.1042/bj20021902 · DOI
  33. Hsu, 2006, The UCSC Known Genes, Bioinformatics, 22, 1036, 10.1093/bioinformatics/btl048 · DOI · Paper page
  34. McLean, 2010, GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol., 28, 495, 10.1038/nbt.1630 · DOI · Paper page
  35. Quinlan, 2010, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics., 26, 841, 10.1093/bioinformatics/btq033 · DOI · Paper page
  36. Sadasivam, 2012, The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression, Genes Dev., 26, 474, 10.1101/gad.181933.111 · DOI · Paper page
  37. Down, 2012, Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb, Biochim. Biophys. Acta, 1819, 855, 10.1016/j.bbagrm.2012.03.008 · DOI
  38. Chen, 2013, The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism, Mol. Cell Biol., 33, 227, 10.1128/MCB.00881-12 · DOI · Paper page
  39. Aggarwal, 2008, Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein, Cancer Res., 68, 981, 10.1158/0008-5472.CAN-06-0249 · DOI · Paper page
  40. Tan, 2012, cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a, Proc. Natl Acad. Sci. USA, 109, 15805, 10.1073/pnas.1207787109 · DOI · Paper page
  41. Bar-Joseph, 2008, Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells, Proc. Natl Acad. Sci. USA, 105, 955, 10.1073/pnas.0704723105 · DOI · Paper page
  42. Nikulenkov, 2012, Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis, Cell Death Differ., 19, 1992, 10.1038/cdd.2012.89 · DOI · Paper page
  43. Li, 2005, SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing, Neoplasia, 7, 312, 10.1593/neo.04325 · DOI
  44. O'Farrell, 2004, Comparison of the effect of mutant and wild-type p53 on global gene expression, Cancer Res., 64, 8199, 10.1158/0008-5472.CAN-03-3639 · DOI · Paper page
  45. Spardy, 2009, Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin, Cancer Res., 69, 7022, 10.1158/0008-5472.CAN-09-0925 · DOI · Paper page
  46. Shin, 2009, Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis, Cancer Res., 69, 5656, 10.1158/0008-5472.CAN-08-3711 · DOI
  47. Rosty, 2005, Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma, Oncogene, 24, 7094, 10.1038/sj.onc.1208854 · DOI · Paper page
  48. Thierry, 2004, A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis, Cancer Res., 64, 895, 10.1158/0008-5472.CAN-03-2349 · DOI
  49. Teissier, 2007, A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells, J. Virol., 81, 9368, 10.1128/JVI.00427-07 · DOI
  50. Myslinski, 2007, Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143, Nucleic Acids Res., 35, 3453, 10.1093/nar/gkm239 · DOI
  51. Evans, 1989, Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences, J. Biol. Chem., 264, 14361, 10.1016/S0021-9258(18)71686-4 · DOI · Paper page
  52. ENCODE Project Consortium, 2011, A user's guide to the encyclopedia of DNA elements (ENCODE), PLoS Biol., 9, e1001046, 10.1371/journal.pbio.1001046 · DOI · Paper page
  53. Herzig, 2000, Sequential serum-dependent activation of CREB and NRF-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c, J. Biol. Chem., 275, 13134, 10.1074/jbc.275.17.13134 · DOI · Paper page
  54. Desdouets, 1996, ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter, FEBS Lett., 385, 34, 10.1016/0014-5793(96)00330-4 · DOI
  55. Johannessen, 2004, What turns CREB on?, Cell Signal., 16, 1211, 10.1016/j.cellsig.2004.05.001 · DOI · Paper page
  56. Liang, 2006, Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation, J. Biol. Chem., 281, 30479, 10.1074/jbc.M607468200 · DOI · Paper page
  57. Tullai, 2007, Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells, J. Biol. Chem., 282, 9482, 10.1074/jbc.M700067200 · DOI
  58. Tullai, 2011, A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells, Cell Cycle, 10, 3072, 10.4161/cc.10.18.17321 · DOI
  59. Elkon, 2003, Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells, Genome Res., 13, 773, 10.1101/gr.947203 · DOI · Paper page
  60. Fischer, 2013, p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes, PLoS One, 8, e63187, 10.1371/journal.pone.0063187 · DOI · Paper page
  61. Imbriano, 2012, The NF-Y/p53 liaison: well beyond repression, Biochim. Biophys. Acta, 1825, 131
  62. Botcheva, 2011, Distinct p53 genomic binding patterns in normal and cancer-derived human cells, Cell Cycle, 10, 4237, 10.4161/cc.10.24.18383 · DOI · Paper page
  63. Dobbelstein, 2013, Interchanging heads: p53 re-composes the DREAM/MMB complex to repress transcription, Cell Cycle, 12, 11, 10.4161/cc.23169 · DOI
  64. Toledo, 1998, Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1, Cell Growth Differ., 9, 887
  65. Gottifredi, 2001, p53 down-regulates CHK1 through p21 and the retinoblastoma protein, Mol. Cell. Biol., 21, 1066, 10.1128/MCB.21.4.1066-1076.2001 · DOI · Paper page
  66. Barboza, 2006, p21 delays tumor onset by preservation of chromosomal stability, Proc. Natl Acad. Sci. USA, 103, 19842, 10.1073/pnas.0606343104 · DOI · Paper page
  67. Bester, 2011, Nucleotide deficiency promotes genomic instability in early stages of cancer development, Cell, 145, 435, 10.1016/j.cell.2011.03.044 · DOI · Paper page
  68. Duensing, 2008, Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms, Virology, 372, 157, 10.1016/j.virol.2007.10.030 · DOI · Paper page
  69. Hickman, 1997, Perturbation of the p53 response by human papillomavirus type 16 E7, J. Virol., 71, 3710, 10.1128/JVI.71.5.3710-3718.1997 · DOI · Paper page
  70. Morozov, 1997, Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21, J. Virol., 71, 3451, 10.1128/JVI.71.5.3451-3457.1997 · DOI · Paper page
  71. Wells, 2000, Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways, EMBO J., 19, 5762, 10.1093/emboj/19.21.5762 · DOI · Paper page
  72. Felsani, 2006, Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins, Oncogene, 25, 5277, 10.1038/sj.onc.1209621 · DOI
  73. Hauser, 2012, Loss of LIN9, a member of the DREAM complex, cooperates with SV40 large T antigen to induce genomic instability and anchorage-independent growth, Oncogene, 31, 1859, 10.1038/onc.2011.364 · DOI
  74. Fine, 2012, Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor, PLoS Pathog., 8, e1002949, 10.1371/journal.ppat.1002949 · DOI

Cited by

See all 59

Metadata

Authors
Fischer, M., Quaas, M., Wintsche, A., Müller, G. A., & Engeland, K.
Venue
Nucleic Acids Research
Published
2013-09-25
Volume
42
Issue
1
Pages
163-180
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2049520975
Cited by
59
References
27
FWCI
2.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.